RPE cells displaying cobblestone morphology. Cells were immunolabeled with tight-junction ZO-1 marker (shown in green) and co-stained with nuclei marker, Hoechst (shown in blue). Image Credit: ...

Retinal pigment epithelium market is poised for notable growth, being fueled by several factors, including an aging population, advancements in AI-driven diagnosis, industry collaborations, and novel ...

Researchers identify five distinct cell subpopulations in the retinal pigment epithelium using artificial intelligence (AI), which could explain different severities of retinal degenerative diseases.

Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) ...

Clinical trials for a laser treatment targeting this common eye disease will begin in Finland next spring, and researchers hope it could become available to patients within three years. About one in ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, No. 21 (May 25, 2021), pp. 1-12 (12 pages) Loss of the retinal pigment epithelium (RPE) because of ...

Japan’s Pharmaceutical and Medical Devices Agency has cleared Healios K.K. and Sumitomo Pharma Co. Ltd. to begin a phase I/II study of HLCR-011, which is composed of retinal pigment epithelial (RPE) ...

Retinal degeneration leads to irreversible vision loss, significantly impacting quality of life. Approximately 19.83 million Americans over 40 have age-related macular degeneration (AMD), a leading ...

Dysregulation of retinal pigment epithelium (RPE) cells is the main cause of a variety of ocular diseases. Potentially heat shock proteins, by preventing molecular and cellular damage and modulating ...